Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival.

Saved in:
Bibliographic Details
Title: Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival.
Authors: Morra, Anna1 (AUTHOR), Schreurs, Maartje A. C.2 (AUTHOR), Andrulis, Irene L.3,4 (AUTHOR), Anton‐Culver, Hoda5 (AUTHOR), Augustinsson, Annelie6 (AUTHOR), Beckmann, Matthias W.7 (AUTHOR), Behrens, Sabine8 (AUTHOR), Bojesen, Stig E.9,10,11 (AUTHOR), Bolla, Manjeet K.12 (AUTHOR), Brauch, Hiltrud13,14,15 (AUTHOR), Broeks, Annegien1 (AUTHOR), Buys, Saundra S.16 (AUTHOR), Camp, Nicola J.16 (AUTHOR), Castelao, Jose E.17 (AUTHOR), Cessna, Melissa H.18 (AUTHOR), Chang‐Claude, Jenny8,19 (AUTHOR), Chung, Wendy K.20 (AUTHOR), Sahlberg, Kristine K. (AUTHOR), Børresen‐Dale, Anne‐Lise (AUTHOR), Gram, Inger Torhild (AUTHOR)
Source: Cancer Medicine. Aug2023, Vol. 12 Issue 15, p16142-16162. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.6272